pubmed-article:15273335 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:15273335 | lifeskim:mentions | umls-concept:C0019829 | lld:lifeskim |
pubmed-article:15273335 | lifeskim:mentions | umls-concept:C0024305 | lld:lifeskim |
pubmed-article:15273335 | lifeskim:mentions | umls-concept:C0332305 | lld:lifeskim |
pubmed-article:15273335 | lifeskim:mentions | umls-concept:C0872169 | lld:lifeskim |
pubmed-article:15273335 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:15273335 | pubmed:dateCreated | 2004-8-30 | lld:pubmed |
pubmed-article:15273335 | pubmed:abstractText | To retrospectively compare diagnostic value of coregistered fluorine 18 fluorodeoxyglucose positron emission tomographic (PET) and computed tomographic (CT) scans obtained with low-dose nonenhanced CT (PET/CT) with those routinely obtained with contrast material-enhanced CT for staging and restaging of disease in patients with Hodgkin disease or high-grade non-Hodgkin lymphoma. | lld:pubmed |
pubmed-article:15273335 | pubmed:language | eng | lld:pubmed |
pubmed-article:15273335 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15273335 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:15273335 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15273335 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15273335 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15273335 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:15273335 | pubmed:month | Sep | lld:pubmed |
pubmed-article:15273335 | pubmed:issn | 0033-8419 | lld:pubmed |
pubmed-article:15273335 | pubmed:author | pubmed-author:SeifertBurkha... | lld:pubmed |
pubmed-article:15273335 | pubmed:author | pubmed-author:GoerresGerhar... | lld:pubmed |
pubmed-article:15273335 | pubmed:author | pubmed-author:von... | lld:pubmed |
pubmed-article:15273335 | pubmed:author | pubmed-author:HanyThomas... | lld:pubmed |
pubmed-article:15273335 | pubmed:author | pubmed-author:StumpeKatrin... | lld:pubmed |
pubmed-article:15273335 | pubmed:author | pubmed-author:TavernaChrist... | lld:pubmed |
pubmed-article:15273335 | pubmed:author | pubmed-author:SchaeferNikla... | lld:pubmed |
pubmed-article:15273335 | pubmed:copyrightInfo | Copyright RSNA, 2004 | lld:pubmed |
pubmed-article:15273335 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:15273335 | pubmed:volume | 232 | lld:pubmed |
pubmed-article:15273335 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:15273335 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:15273335 | pubmed:pagination | 823-9 | lld:pubmed |
pubmed-article:15273335 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:15273335 | pubmed:meshHeading | pubmed-meshheading:15273335... | lld:pubmed |
pubmed-article:15273335 | pubmed:meshHeading | pubmed-meshheading:15273335... | lld:pubmed |
pubmed-article:15273335 | pubmed:meshHeading | pubmed-meshheading:15273335... | lld:pubmed |
pubmed-article:15273335 | pubmed:meshHeading | pubmed-meshheading:15273335... | lld:pubmed |
pubmed-article:15273335 | pubmed:meshHeading | pubmed-meshheading:15273335... | lld:pubmed |
pubmed-article:15273335 | pubmed:meshHeading | pubmed-meshheading:15273335... | lld:pubmed |
pubmed-article:15273335 | pubmed:meshHeading | pubmed-meshheading:15273335... | lld:pubmed |
pubmed-article:15273335 | pubmed:meshHeading | pubmed-meshheading:15273335... | lld:pubmed |
pubmed-article:15273335 | pubmed:meshHeading | pubmed-meshheading:15273335... | lld:pubmed |
pubmed-article:15273335 | pubmed:meshHeading | pubmed-meshheading:15273335... | lld:pubmed |
pubmed-article:15273335 | pubmed:meshHeading | pubmed-meshheading:15273335... | lld:pubmed |
pubmed-article:15273335 | pubmed:meshHeading | pubmed-meshheading:15273335... | lld:pubmed |
pubmed-article:15273335 | pubmed:meshHeading | pubmed-meshheading:15273335... | lld:pubmed |
pubmed-article:15273335 | pubmed:meshHeading | pubmed-meshheading:15273335... | lld:pubmed |
pubmed-article:15273335 | pubmed:meshHeading | pubmed-meshheading:15273335... | lld:pubmed |
pubmed-article:15273335 | pubmed:meshHeading | pubmed-meshheading:15273335... | lld:pubmed |
pubmed-article:15273335 | pubmed:meshHeading | pubmed-meshheading:15273335... | lld:pubmed |
pubmed-article:15273335 | pubmed:year | 2004 | lld:pubmed |
pubmed-article:15273335 | pubmed:articleTitle | Non-Hodgkin lymphoma and Hodgkin disease: coregistered FDG PET and CT at staging and restaging--do we need contrast-enhanced CT? | lld:pubmed |
pubmed-article:15273335 | pubmed:affiliation | Department of Nuclear Medicine, University Hospital Zurich, Raemistrasse 100, CH-8091 Zurich, Switzerland. | lld:pubmed |
pubmed-article:15273335 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:15273335 | pubmed:publicationType | Comparative Study | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15273335 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15273335 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15273335 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15273335 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15273335 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15273335 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15273335 | lld:pubmed |